taVNS Paired With Bottle Feeding in Infants Failing Oral Feeds
Study Details
Study Description
Brief Summary
Oromotor dysfunction and poor feeding is common after premature birth and hypoxic ischemic encephalopathy (HIE). Pairing vagus nerve stimulation (VNS) with motor activity accelerates functional improvements after stroke. This study is designed to investigate whether transcutaneous auricular VNS (taVNS) paired with oromotor rehabilitation is tolerable, safe, and facilitates motor learning in infants who have failed oral feeding.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Early Phase 1 |
Detailed Description
Feeding difficulty is the primary reason for delayed hospital discharge from the neonatal intensive care unit (NICU), with increased hospital costs and a negative impact on neurodevelopment. Occupational or speech therapists typically start oral stimulation programs early, then feed infants by mouth (PO) daily to encourage safe feeding while learning this motor skill. Even after weeks or months of rehabilitation with therapists, many infants need a gastrostomy tube (G-tube) surgically placed for adequate nutrition. With improved survival rates of more critically ill neonates, the national rate of G-tube placement has doubled from 2000-2012.
Difficulty learning the motor sequence for oral feeding may be due to brain injury from infection, ischemia, and dysmaturity. In these infants, the normal integrative connectivity that occurs after birth between the cortex, basal ganglia, and brainstem may be disturbed, resulting in poor coordination and failure to learn the complex motor task of feeding, when it should be a normal reflex. Therapies that facilitate motor learning and enhance feeding skills would have a significant impact for infants who fail feeding rehabilitation.
In neonates with brain dysmaturity or overt brain injury, neuromodulation of abnormal circuits may positively boost neuronal connectivity and enhance neuroplasticity. Vagus nerve stimulation (VNS) paired with motor activity facilitates cortical reorganization and neurogenesis, and improves motor function in animal stroke models. A noninvasive form of VNS, transcutaneous auricular VNS (taVNS), targets the auricular branch of the vagus nerve to activate vagal afferent and efferent networks. In adult patients with limb impairment after brain injury, pairing taVNS with motor activation is safe, enhances plasticity and improves functional motor recovery. This work in adult humans extends and supports the animal evidence that pairing VNS with a motor or behavioral intervention restores brain function.
The study investigators applied the model of taVNS paired with a motor behavior to infants in the NICU in a prospective, open-label trial exploring the use of once and twice daily taVNS-paired rehabilitation training to enhance oral feeding in infants who are failing oral feeds and slated to receive a G-tube.
After obtaining informed consent, MRIs are obtained before starting treatment, and at end of 2-3 week treatment period. In a subset of 10 patients the study investigators also obtain modified barium swallows prior to and after the treatment period, with taVNS on and off during swallowing. Daily feeding volumes as well as the slope of change of po feeding volumes are recorded before and after starting taVNS.
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Experimental: taVNS once daily taVNS paired with bottle feeding once daily for 2-3 weeks |
Device: transcutaneous auricular vagus nerve stimulation
Microcurrent stimulation delivered to the left tragus, with stimulation 'on' during sucking from a bottle, and 'off' at rest during bottle feeding
Other Names:
|
| Experimental: taVNS twice daily taVNS paired with bottle feeding twice daily for 2-3 weeks |
Device: transcutaneous auricular vagus nerve stimulation
Microcurrent stimulation delivered to the left tragus, with stimulation 'on' during sucking from a bottle, and 'off' at rest during bottle feeding
Other Names:
|
Outcome Measures
Primary Outcome Measures
- Number of infants that achieve full oral feeds (Responders) vs those that cannot achieve full oral feeds and receive a G-tube (Non-responders) [3 weeks]
full oral feeds or G-tube implantation. Responders were participants who were able to increase and maintain full daily PO intake for 4 days (>120 ml/kg/day) and weight gain adequate for discharge (>20 g/day). Infants who received G-tubes for inadequate intake after taVNS treatment were classified as non-responders.
- The change in ml/kg/d of oral feeds over the 7 days before and 7 days during taVNS-paired feeds [3 weeks]
Rate of increase of daily oral feeding volumes in once vs twice daily taVNS-paired with bottle feeding
- Neuroplasticity as measured by the change in white matter tract integrity via fractional anisotropy [3 weeks]
changes in diffusion in white matter tracts important in oromotor coordination from before to after taVNS treatment by diffusion imaging
Secondary Outcome Measures
- Target attainment for taVNS stimulation, as measured by change in heart rate at onset of stimulation [1 week, onset of taVNS stimulation for 5 min]
Lowest heart rate within the first 60 sec of stimulation and the rebound HR, to verify target engagement of vagus nerve using the parasympathetic response as an indicator during taVNS-paired feeds versus control feeds with no stimulation.
- number of episodes of bradycardia [3 weeks, during taVNS sessions]
bradycardic episodes = heart rate <80 beats per minute for 5 seconds
- Increase of 3 points in Neonatal and infant pain scale (NIPS) scores from before to during taVNS [3 weeks]
NIPS recorded at initiation, midway, end of each treatment session
Eligibility Criteria
Criteria
Inclusion Criteria:
- Infants must be clinically stable, on minimal respiratory support (nasal cannula, or room air), are not restricted for attempting every feed by mouth, and are currently failing oral feeding such that the clinical team is broaching gastrostomy tube (G-tube) placement with the parents. The infant will be greater than or equal to 39weeks gestation at enrollment and either
-
Premature at birth and attempting oral feeds for at least 3 weeks or
-
Infants who are neart-term or term at birth, with significant medical issues that have precluded oral feeding, such as hypoxic ischemic encephalopathy (HIE), and attempting oral feeds for at least 2 weeks.
Exclusion Criteria:
-
Unstable infants or those requiring positive pressure respiratory support.
-
Infants <38weeks gestation at enrollment.
-
Major unrepaired congenital anomalies or anomalies that limit feeding volumes
-
Cardiomyopathy
-
Repeated episodes of autonomic instability (apnea or bradycardia) which are not self resolving
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Medical University of South Carolina | Charleston | South Carolina | United States | 29425 |
Sponsors and Collaborators
- Medical University of South Carolina
- National Institute of General Medical Sciences (NIGMS)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Investigators
- Principal Investigator: Dorothea Jenkins, MD, Medical University of South Carolina
- Principal Investigator: Bashar Badran, PhD, Medical University of South Carolina
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 67997
- P20GM109040
- P2CHD086844